Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
GM-CSF–deficient mice are susceptible to pulmonary group B streptococcal infection
Ann Marie LeVine, … , Eli Cianciolo, Jeffrey A. Whitsett
Ann Marie LeVine, … , Eli Cianciolo, Jeffrey A. Whitsett
Published February 15, 1999
Citation Information: J Clin Invest. 1999;103(4):563-569. https://doi.org/10.1172/JCI5212.
View: Text | PDF
Article

GM-CSF–deficient mice are susceptible to pulmonary group B streptococcal infection

  • Text
  • PDF
Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-targeted mice (GM–/–) cleared group B streptococcus (GBS) from the lungs more slowly than wild-type mice. Expression of GM-CSF in the respiratory epithelium of GM–/– mice improved bacterial clearance to levels greater than that in wild-type GM+/+ mice. Acute aerosolization of GM-CSF to GM+/+ mice significantly enhanced clearance of GBS at 24 hours. GBS infection was associated with increased neutrophilic infiltration in lungs of GM–/– mice, while macrophage infiltrates predominated in wild-type mice, suggesting an abnormality in macrophage clearance of bacteria in the absence of GM-CSF. While phagocytosis of GBS was unaltered, production of superoxide radicals and hydrogen peroxide was markedly deficient in macrophages from GM–/– mice. Lipid peroxidation, assessed by measuring the isoprostane 8-iso-PGF2α, was decreased in the lungs of GM–/– mice. GM-CSF plays an important role in GBS clearance in vivo, mediated in part by its role in enhancing superoxide and hydrogen peroxide production and bacterial killing by alveolar macrophages.

Authors

Ann Marie LeVine, Jacquelyn A. Reed, Kim E. Kurak, Eli Cianciolo, Jeffrey A. Whitsett

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Increased nitrite concentrations in BAL fluid from GM–/– mice after GBS ...
Increased nitrite concentrations in BAL fluid from GM–/– mice after GBS infection. Nitrite in the BAL fluid was measured by the Griess reaction as described in Methods. Six and 24 h after intratracheal inoculation of 104 CFU GBS, nitrite (a) and nitrite/nitrate (b) levels in BAL fluid from GM–/– mice (solid bars) were increased compared with GM+/+ (hatched bars) and SP-C-GM (open bars) mice. Data represent mean ± SEM with n = 5 mice per group. *P < 0.05 compared with GM+/+ mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts